nodes	percent_of_prediction	percent_of_DWPC	metapath
Carteolol—Eyelid ptosis—Dexamethasone—ankylosing spondylitis	0.0873	0.0873	CcSEcCtD
Carteolol—Eyelid ptosis—Betamethasone—ankylosing spondylitis	0.0873	0.0873	CcSEcCtD
Carteolol—Diabetic—Methylprednisolone—ankylosing spondylitis	0.036	0.036	CcSEcCtD
Carteolol—Diabetic—Dexamethasone—ankylosing spondylitis	0.0328	0.0328	CcSEcCtD
Carteolol—Diabetic—Betamethasone—ankylosing spondylitis	0.0328	0.0328	CcSEcCtD
Carteolol—Conjunctival hyperaemia—Prednisolone—ankylosing spondylitis	0.0298	0.0298	CcSEcCtD
Carteolol—Conjunctival hyperaemia—Dexamethasone—ankylosing spondylitis	0.0249	0.0249	CcSEcCtD
Carteolol—Conjunctival hyperaemia—Betamethasone—ankylosing spondylitis	0.0249	0.0249	CcSEcCtD
Carteolol—Diabetic—Methotrexate—ankylosing spondylitis	0.0239	0.0239	CcSEcCtD
Carteolol—Keratitis—Prednisolone—ankylosing spondylitis	0.0202	0.0202	CcSEcCtD
Carteolol—Keratitis—Dexamethasone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Carteolol—Keratitis—Betamethasone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Carteolol—Eye irritation—Prednisolone—ankylosing spondylitis	0.0154	0.0154	CcSEcCtD
Carteolol—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Carteolol—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.0105	0.0105	CcSEcCtD
Carteolol—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Carteolol—Visual disturbance—Prednisolone—ankylosing spondylitis	0.01	0.01	CcSEcCtD
Carteolol—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.01	0.01	CcSEcCtD
Carteolol—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.00965	0.00965	CcSEcCtD
Carteolol—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.00963	0.00963	CcSEcCtD
Carteolol—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.00913	0.00913	CcSEcCtD
Carteolol—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.00913	0.00913	CcSEcCtD
Carteolol—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.00876	0.00876	CcSEcCtD
Carteolol—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.00876	0.00876	CcSEcCtD
Carteolol—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00838	0.00838	CcSEcCtD
Carteolol—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00838	0.00838	CcSEcCtD
Carteolol—Respiratory failure—Methotrexate—ankylosing spondylitis	0.00811	0.00811	CcSEcCtD
Carteolol—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.00795	0.00795	CcSEcCtD
Carteolol—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.00763	0.00763	CcSEcCtD
Carteolol—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.00743	0.00743	CcSEcCtD
Carteolol—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00713	0.00713	CcSEcCtD
Carteolol—Bradycardia—Prednisolone—ankylosing spondylitis	0.0067	0.0067	CcSEcCtD
Carteolol—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.00665	0.00665	CcSEcCtD
Carteolol—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00656	0.00656	CcSEcCtD
Carteolol—Visual impairment—Prednisolone—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Carteolol—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00617	0.00617	CcSEcCtD
Carteolol—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00615	0.00615	CcSEcCtD
Carteolol—Visual disturbance—Methotrexate—ankylosing spondylitis	0.0061	0.0061	CcSEcCtD
Carteolol—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00595	0.00595	CcSEcCtD
Carteolol—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00595	0.00595	CcSEcCtD
Carteolol—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Carteolol—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00588	0.00588	CcSEcCtD
Carteolol—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00582	0.00582	CcSEcCtD
Carteolol—Bradycardia—Betamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Carteolol—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Carteolol—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00541	0.00541	CcSEcCtD
Carteolol—Vision blurred—Prednisolone—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Carteolol—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Carteolol—Depression—Prednisone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Carteolol—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Carteolol—Visual impairment—Betamethasone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Carteolol—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00516	0.00516	CcSEcCtD
Carteolol—Syncope—Prednisolone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Carteolol—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Carteolol—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Carteolol—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Carteolol—Bradycardia—Prednisone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Carteolol—Syncope—Triamcinolone—ankylosing spondylitis	0.00473	0.00473	CcSEcCtD
Carteolol—Syncope—Methylprednisolone—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Carteolol—Oedema—Prednisolone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Carteolol—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Carteolol—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Carteolol—Shock—Prednisolone—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Carteolol—Depression—Methotrexate—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Carteolol—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Carteolol—Oedema—Triamcinolone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Carteolol—Syncope—Betamethasone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Carteolol—Syncope—Dexamethasone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Carteolol—Arrhythmia—Prednisone—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Carteolol—Shock—Triamcinolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Carteolol—Insomnia—Prednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Carteolol—Shock—Methylprednisolone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Carteolol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Carteolol—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Carteolol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Carteolol—Vision blurred—Prednisone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Carteolol—Oedema—Dexamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Carteolol—Oedema—Betamethasone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Carteolol—Insomnia—Triamcinolone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Carteolol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Carteolol—Visual impairment—Methotrexate—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Carteolol—Shock—Dexamethasone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Carteolol—Shock—Betamethasone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Carteolol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Carteolol—Syncope—Prednisone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Carteolol—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Carteolol—Hypotension—Dexamethasone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Carteolol—Hypotension—Betamethasone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Carteolol—Insomnia—Dexamethasone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Carteolol—Insomnia—Betamethasone—ankylosing spondylitis	0.00353	0.00353	CcSEcCtD
Carteolol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Carteolol—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Carteolol—Oedema—Prednisone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Carteolol—Shock—Prednisone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Carteolol—Vision blurred—Methotrexate—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Carteolol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Carteolol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Carteolol—Dizziness—Prednisolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Carteolol—Asthenia—Triamcinolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Carteolol—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Carteolol—Insomnia—Prednisone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Carteolol—Headache—Prednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Carteolol—Dizziness—Triamcinolone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Carteolol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Carteolol—Asthenia—Betamethasone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Carteolol—Asthenia—Dexamethasone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Carteolol—Nausea—Prednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Carteolol—Headache—Triamcinolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Carteolol—Headache—Methylprednisolone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Carteolol—Hypotension—Methotrexate—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Carteolol—Dizziness—Dexamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Carteolol—Dizziness—Betamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Carteolol—Insomnia—Methotrexate—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Carteolol—Nausea—Triamcinolone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Carteolol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Carteolol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Carteolol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Carteolol—Headache—Dexamethasone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Carteolol—Headache—Betamethasone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Carteolol—Asthenia—Prednisone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Carteolol—Nausea—Dexamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Carteolol—Nausea—Betamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Carteolol—Dizziness—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Carteolol—Headache—Prednisone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Carteolol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Carteolol—Asthenia—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Carteolol—Nausea—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Carteolol—Dizziness—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Carteolol—Headache—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Carteolol—Nausea—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
